Contributions of ProglucagonPia

Contributions by ProglucagonPia, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 2,922 edits includes activity predating the current log.

1. 14:03, 21 Jun 2026 (diff | hist) Vial 26,012 ±0 fix significant figures — source gives fewer
2. 03:28, 14 Jun 2026 (diff | hist) Enteroendocrine L cell 5,083 ±0 British spelling per PP:MOS
3. 20:40, 7 Apr 2026 (diff | hist) Incretin effect 7,358 ±0 attribute claim in-text
4. 16:29, 15 Feb 2026 (diff | hist) Xi'an Mokemei Biotechnology 12,475 +186 hedge overclaim
5. 07:38, 15 Feb 2026 (diff | hist) WuXi TIDES 13,269 ±0 fix arithmetic in worked example
6. 00:07, 3 Feb 2026 (diff | hist) Incretin effect 7,358 ±0 m promote subsection to section
7. 19:28, 16 Sep 2025 (diff | hist) Glucose-dependent insulinotropic polypeptide 8,265 ±0 add confidence interval
8. 09:51, 19 Aug 2025 (diff | hist) Zhuhai Kerui Biotechnology 6,440 +530 convert list to prose
9. 15:58, 11 Aug 2025 (diff | hist) Karl Fischer titration 8,741 ±0 m fix arithmetic in worked example
10. 08:31, 4 Aug 2025 (diff | hist) WuXi TIDES 11,140 ±0 expand §Regulatory position and legal status
11. 13:05, 2 Jul 2025 (diff | hist) Temperature excursion 10,953 ±0 clarify whether figure is gross or net mass
12. 15:43, 12 Apr 2025 (diff | hist) Glucose-dependent insulinotropic polypeptide 6,686 ±0 m replace primary source with the review
13. 14:54, 7 Apr 2025 (diff | hist) Glucagon-like peptide-1 10,239 ±0 m add category
14. 00:31, 7 Jan 2025 (diff | hist) Glucose-dependent insulinotropic polypeptide 6,231 +626 tag ^{[citation needed]}
15. 17:05, 19 Dec 2024 (diff | hist) Enteroendocrine L cell 3,466 ±0 add category
16. 03:06, 7 Oct 2024 (diff | hist) Bachem Holding (Suzhou) 1,686 ±0 attribute range as a review estimate per talk
17. 11:54, 19 Jun 2024 (diff | hist) Glucagon-like peptide-1 1,486 ±0 expand §Physiological actions